relation: https://arxiv.academicsbook.com/id/eprint/10660/
title: TREATMENT OF PATISIRAN IN PATIENTS WHO HAS TRANSTHYRETIN CARDIAC AMYLOIDOSIS
creator: Abdulhamid, Haydarov
description: Transthyretin amyloidosis, also called ATTR amyloidosis, is associated with accumulation of ATTR amyloid deposits in the heart and commonly manifests as progressive cardiomyopathy. Patisiran, an RNA interference therapeutic agent, inhibits the production of hepatic transthyretin
publisher: “CENTER FOR ADVANCED STUDIES” LLC
date: 2024-02-27
type: Article
type: NonPeerReviewed
identifier:   Abdulhamid, Haydarov  (2024) TREATMENT OF PATISIRAN IN PATIENTS WHO HAS TRANSTHYRETIN CARDIAC AMYLOIDOSIS.  INTERNATIONAL JOURNAL OF RECENTLY SCIENTIFIC RESEARCHER'S THEORY; Vol. 2 No. 2 (2024): INTERNATIONAL JOURNAL OF RECENTLY SCIENTIFIC RESEARCHER'S THEORY; 283-292.       
relation: https://uzresearchers.com/index.php/ijrs/article/view/2149